BPA
NUVB icon

Beacon Pointe Advisors’s Nuvation Bio NUVB Stock Holding History

Beacon Pointe Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.76M Buy
643,734
+384,522
+148% +$2.14M 0.01% 639
2025
Q4 		$2.32M Buy
259,212
+97,612
+60% +$605K 0.02% 562
2025
Q3 		$598K Sell
161,600
-50,350
-24% -$137K 0.01% 947
2025
Q2 		$413K Buy
211,950
+84,900
+67% +$177K ﹤0.01% 942
2025
Q1 		$224K Buy
127,050
+73,500
+137% +$167K ﹤0.01% 1119
2024
Q4 		$142K Buy
+53,550
New +$138K ﹤0.01% 1167
2024
Q2 		– Sell
-21,700
Closed -$79K – 1352
2024
Q1 		$79K Hold
21,700
– – ﹤0.01% 1317
2023
Q4 		$32.8K Buy
+21,700
New +$27.9K ﹤0.01% 1303

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Beacon Pointe Advisors's NUVB Position: Q1 2026 in Review

Beacon Pointe Advisors increased its Nuvation Bio (NUVB) stake by 148% in Q1 2026, buying an estimated $2.14M and bringing the position to 643,734 shares worth $2.76M. The position accounts for 0.01% of the portfolio, ranked #639.

Beacon Pointe Advisors first reported a position in NUVB in Q4 2023 and has held it in 8 quarters since. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Beacon Pointe Advisors held 643,734 shares of Nuvation Bio worth $2.76M as of Q1 2026.
  • Beacon Pointe Advisors bought 384,522 Nuvation Bio shares in Q1 2026, an estimated $2.14M.
  • Nuvation Bio made up 0.01% of Beacon Pointe Advisors's portfolio in Q1 2026, its #639 holding.
  • Beacon Pointe Advisors first reported a position in Nuvation Bio in Q4 2023 and has held it in 8 quarters since.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Beacon Pointe Advisors's 13F filing for Q1 2026, filed 15 May 2026.